Secukinumab in patients with Psoriatic Arthritis and Axial Manifestation. Save

Sponsored by Novartis Medical Affairs - Listen to Xenofon Baraliakos discuss secukinumab in patients with Psoriatic Arthritis and Axial Manifestation: results from the double-blind, randomised, phase 3 MAXIMISE trial.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.